Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia

Curtiss B. Cook, Todd B. Nippoldt, Gad B. Kletter, Robert P. Kelch, John C. Marshall

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The ability to change the frequency and amplitude of pulsatile GnRH secretion may be an important mechanism in maintaining regular ovulatory cycles. Hyperprolactinemia is associated with anovulation and slow frequency LH (GnRH) secretion in women. To assess whether the slow frequency of LH (GnRH) secretion is due to increased opioid activity, we examined the effect of naloxone infusions in eight amenorrheic hyperprolactinemic women (mean ± SE, serum PRL, 160 ± 59 μg/L). After a baseline period, either saline or naloxone was infused for 8 h on separate days, and LH was measured in blood obtained at 15-min intervals. Additional samples were obtained for plasma FSH, PRL, estradiol, and progesterone. Responses to exogenous GnRH were assessed at the end of the infusions. LH pulse frequency increased in all subjects from a mean of 4.0 ± 0.5 pulses/10 h (mean ± SE) during saline infusion to 8.0 ± 1.0 pulses/10 h during naloxone infusion (P < 0.01). LH pulse amplitude did not change, and mean plasma LH increased from 7.4 ± 0.8 IU/L (±SE) to 11.2 ± 1.5 IU/L during naloxone (P < 0.01). A small but significant increase was seen in mean plasma FSH. Plasma PRL, estradiol, and progesterone were unchanged by naloxone infusion. These data suggest that elevated serum PRL reduces the frequency of LH (GnRH) secretion by increasing hypothalamic opioid activity and suggest that the anovulation in hyperprolactinemia is consequent upon persistent slow frequency LH (GnRH) secretion.

Original languageEnglish (US)
Pages (from-to)1099-1105
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume73
Issue number5
StatePublished - Nov 1991
Externally publishedYes

Fingerprint

Hyperprolactinemia
Naloxone
Luteinizing Hormone
Gonadotropin-Releasing Hormone
Anovulation
Plasmas
Opioid Analgesics
Progesterone
Estradiol
Serum
Blood

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Cook, C. B., Nippoldt, T. B., Kletter, G. B., Kelch, R. P., & Marshall, J. C. (1991). Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia. Journal of Clinical Endocrinology and Metabolism, 73(5), 1099-1105.

Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia. / Cook, Curtiss B.; Nippoldt, Todd B.; Kletter, Gad B.; Kelch, Robert P.; Marshall, John C.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 73, No. 5, 11.1991, p. 1099-1105.

Research output: Contribution to journalArticle

Cook, CB, Nippoldt, TB, Kletter, GB, Kelch, RP & Marshall, JC 1991, 'Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia', Journal of Clinical Endocrinology and Metabolism, vol. 73, no. 5, pp. 1099-1105.
Cook, Curtiss B. ; Nippoldt, Todd B. ; Kletter, Gad B. ; Kelch, Robert P. ; Marshall, John C. / Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia. In: Journal of Clinical Endocrinology and Metabolism. 1991 ; Vol. 73, No. 5. pp. 1099-1105.
@article{7ddf8af7a00148a6af79bb22d53f18b9,
title = "Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia",
abstract = "The ability to change the frequency and amplitude of pulsatile GnRH secretion may be an important mechanism in maintaining regular ovulatory cycles. Hyperprolactinemia is associated with anovulation and slow frequency LH (GnRH) secretion in women. To assess whether the slow frequency of LH (GnRH) secretion is due to increased opioid activity, we examined the effect of naloxone infusions in eight amenorrheic hyperprolactinemic women (mean ± SE, serum PRL, 160 ± 59 μg/L). After a baseline period, either saline or naloxone was infused for 8 h on separate days, and LH was measured in blood obtained at 15-min intervals. Additional samples were obtained for plasma FSH, PRL, estradiol, and progesterone. Responses to exogenous GnRH were assessed at the end of the infusions. LH pulse frequency increased in all subjects from a mean of 4.0 ± 0.5 pulses/10 h (mean ± SE) during saline infusion to 8.0 ± 1.0 pulses/10 h during naloxone infusion (P < 0.01). LH pulse amplitude did not change, and mean plasma LH increased from 7.4 ± 0.8 IU/L (±SE) to 11.2 ± 1.5 IU/L during naloxone (P < 0.01). A small but significant increase was seen in mean plasma FSH. Plasma PRL, estradiol, and progesterone were unchanged by naloxone infusion. These data suggest that elevated serum PRL reduces the frequency of LH (GnRH) secretion by increasing hypothalamic opioid activity and suggest that the anovulation in hyperprolactinemia is consequent upon persistent slow frequency LH (GnRH) secretion.",
author = "Cook, {Curtiss B.} and Nippoldt, {Todd B.} and Kletter, {Gad B.} and Kelch, {Robert P.} and Marshall, {John C.}",
year = "1991",
month = "11",
language = "English (US)",
volume = "73",
pages = "1099--1105",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia

AU - Cook, Curtiss B.

AU - Nippoldt, Todd B.

AU - Kletter, Gad B.

AU - Kelch, Robert P.

AU - Marshall, John C.

PY - 1991/11

Y1 - 1991/11

N2 - The ability to change the frequency and amplitude of pulsatile GnRH secretion may be an important mechanism in maintaining regular ovulatory cycles. Hyperprolactinemia is associated with anovulation and slow frequency LH (GnRH) secretion in women. To assess whether the slow frequency of LH (GnRH) secretion is due to increased opioid activity, we examined the effect of naloxone infusions in eight amenorrheic hyperprolactinemic women (mean ± SE, serum PRL, 160 ± 59 μg/L). After a baseline period, either saline or naloxone was infused for 8 h on separate days, and LH was measured in blood obtained at 15-min intervals. Additional samples were obtained for plasma FSH, PRL, estradiol, and progesterone. Responses to exogenous GnRH were assessed at the end of the infusions. LH pulse frequency increased in all subjects from a mean of 4.0 ± 0.5 pulses/10 h (mean ± SE) during saline infusion to 8.0 ± 1.0 pulses/10 h during naloxone infusion (P < 0.01). LH pulse amplitude did not change, and mean plasma LH increased from 7.4 ± 0.8 IU/L (±SE) to 11.2 ± 1.5 IU/L during naloxone (P < 0.01). A small but significant increase was seen in mean plasma FSH. Plasma PRL, estradiol, and progesterone were unchanged by naloxone infusion. These data suggest that elevated serum PRL reduces the frequency of LH (GnRH) secretion by increasing hypothalamic opioid activity and suggest that the anovulation in hyperprolactinemia is consequent upon persistent slow frequency LH (GnRH) secretion.

AB - The ability to change the frequency and amplitude of pulsatile GnRH secretion may be an important mechanism in maintaining regular ovulatory cycles. Hyperprolactinemia is associated with anovulation and slow frequency LH (GnRH) secretion in women. To assess whether the slow frequency of LH (GnRH) secretion is due to increased opioid activity, we examined the effect of naloxone infusions in eight amenorrheic hyperprolactinemic women (mean ± SE, serum PRL, 160 ± 59 μg/L). After a baseline period, either saline or naloxone was infused for 8 h on separate days, and LH was measured in blood obtained at 15-min intervals. Additional samples were obtained for plasma FSH, PRL, estradiol, and progesterone. Responses to exogenous GnRH were assessed at the end of the infusions. LH pulse frequency increased in all subjects from a mean of 4.0 ± 0.5 pulses/10 h (mean ± SE) during saline infusion to 8.0 ± 1.0 pulses/10 h during naloxone infusion (P < 0.01). LH pulse amplitude did not change, and mean plasma LH increased from 7.4 ± 0.8 IU/L (±SE) to 11.2 ± 1.5 IU/L during naloxone (P < 0.01). A small but significant increase was seen in mean plasma FSH. Plasma PRL, estradiol, and progesterone were unchanged by naloxone infusion. These data suggest that elevated serum PRL reduces the frequency of LH (GnRH) secretion by increasing hypothalamic opioid activity and suggest that the anovulation in hyperprolactinemia is consequent upon persistent slow frequency LH (GnRH) secretion.

UR - http://www.scopus.com/inward/record.url?scp=0025724916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025724916&partnerID=8YFLogxK

M3 - Article

VL - 73

SP - 1099

EP - 1105

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -